A Bench-to-Bedside Pipeline Story
L.F. DellÕOsso, Ph.D.
I study eye
movements from an engineer's control system point of view and specifically
study ocular motor oscillations (nystagmus and saccadic). In my thinking and
modelling, I consider mainly function and signal/information processing, rather
than anatomy.
In 1978 I was
documenting the effects of the Anderson-Kestenbaum surgery on patients with
congenital nystagmus (CN). Briefly, the extraocular muscles are cut off the
globe and relocated in such a way that patients who used a head turn to look at
things at a gaze angle where their CN was minimal could then do so while
looking in primary position. It's described as moving the null region to straight
ahead. My data showed that in addition to doing that, the operation also
reduced (damped) the CN over a broader range of gaze angles than the preop null
region and also damped the CN at gaze angles lateral to the null.
These secondary
benefits were not previously known and were unexplained. After getting a
description of just how the surgery was done, I hypothesized that the simple
act of cutting the tendon off the globe and sewing it back was causing these
beneficial secondary effects. I further reasoned that for the many CN patients
who did not exhibit a null region and had no surgical option, a simple
"cut-and-sew" procedure would damp their CN, allowing better vision.
Waiting in
the Pipeline: (1979 Ð 1992)
Needless to say,
no surgeon was eager to operate and Ôdo nothingÕ (medical-legal fears) so I
continued my nystagmus research while looking for an animal model.
Later in the
Pipeline: (1992 Ð 1998)
It wasn't until
about 14 years later when studying achiasmatic Belgian sheepdogs with CN in
Memphis that I had the opportunity to put my old hypothesis to the test. I
convinced an ophthalmologist/friend (Rich Hertle) to forgo his lucrative
practice income for a few days and fly to Memphis at his own expense to try my
'tenotomy' operation out on the 4 horizontal rectus muscles of the last dog we
had, before he was sacrificed for anatomical studies. He assured me it wouldn't
work but humored me and, with me as an assistant, performed the surgery while
continually stating that it could not work and would be mal-practice if he were
doing this on a human (it's all on video tape).
The next day we
checked on the dog in the animal facility and his eyes were almost still. Rich
insisted that the lack of nystagmus was due to the anesthesia, which he claimed
had not worn off. I said, "Fine, we'll check again tomorrow." Well,
the CN was still very small and the dog's behavior was suddenly more like that
of a normal dog, so much so that the caretakers thought we had switched dogs on
them. Since the dog also had vertical see-saw nystagmus (SSN) I convinced him
to meet me in Memphis four months later to do the tenotomy on the 4 vertical
recti and 4 oblique muscles. The results were even more spectacular; no SSN
remained.
The light at
the End of the Pipeline: (1999 Ð2003)
On the basis of
my original hypothesis from human data and that one dog, the NEI sponsored a
masked clinical trial on 10 adults and 5 children with CN. The positive results
(improved CN waveforms and visual function) was published for the adults and
are in press for the children. I hypothesized that we had interfered with a
proprioceptive feedback loop that maintains muscle tension, effectively
reducing the small-signal gain of the ocular motor plant to the central
nystagmus signal. The anatomists said, "that can't be; there are no neural
cells at the distal end (enthesis) of the tendon." I replied, "look
again." Well, they did and there were. There are all manner of neural
cells there, supporting my hypothesis. I further hypothesized that since this
mechanism is independent of the specific type of nystagmus, it should work for
acquired types and reduce intractable oscillopsia. Again, the naysayers (this
time ophthalmologists and neurologists) said that it would not work because CN
was 'different' than acquired (adult) nystagmus, ignoring the hypothesized
mechanism of action which was independent of the type of nystagmus.
We recently
tried out the tenotomy procedure on an adult with MS, acquired pendular
nystagmus and intractable oscillopsia and reduced his nystagmus by 78%. We now
have a viable therapy for acquired nystagmus and intractable oscillopsia.
Dr. Story
Landis, in a lecture a Case Western Reserve University, said that although
highly desirable, actual stories of research that led directly from the lab to
the bedside were rare. Those who demand ÔrelevanceÕ of research do not
understand research or how its results often prove useful in ways not
envisioned by the investigator. Never-the-less, the above sequence of events
constitute such a story with promising benefits to patients with nystagmus.